Suchergebnisse - Alan L. Ho

Treffer weiter einschränken
  1. 1
    The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent

    The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent von Jayasree S. Nair, Alan L. Ho, Gary K. Schwartz

    Veröffentlicht 2012
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Regulation of Late G<sub>1</sub>/S Phase Transition and APC<sup>Cdh1</sup>by Reactive Oxygen Species

    Regulation of Late G<sub>1</sub>/S Phase Transition and APC<sup>Cdh1</sup>by Reactive Oxygen Species von Courtney G. Havens, Alan L. Ho, Naohisa Yoshioka, Steven F. Dowdy

    Veröffentlicht 2006
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy

    Locally Advanced and Unresectable Cutaneous Squamous Cell Carcinoma: Outcomes of Concurrent Cetuximab and Radiotherapy von Robert M. Samstein, Alan L. Ho, Nancy Y. Lee, Christopher A. Barker

    Veröffentlicht 2014
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Androgen Receptor Signaling in Salivary Gland Cancer

    Androgen Receptor Signaling in Salivary Gland Cancer von Martin G. Dalin, Philip A. Watson, Alan L. Ho, Luc G.T. Morris

    Veröffentlicht 2017
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Correlation of <i>BRAF</i><sup><i>V600E</i></sup> Mutation and Glucose Metabolism in Thyroid Cancer Patients: An <sup>18</sup>F-FDG PET Study

    Correlation of <i>BRAF</i><sup><i>V600E</i></sup> Mutation and Glucose Metabolism in Thyroid Cancer Patients: An <sup>18</sup>F-FDG PET Study von James Nagarajah, Alan L. Ho, R. Michael Tuttle, Wolfgang Weber, Ravinder K. Grewal

    Veröffentlicht 2015
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Inhibition of Mutant GNAQ Signaling in Uveal Melanoma Induces AMPK-Dependent Autophagic Cell Death

    Inhibition of Mutant GNAQ Signaling in Uveal Melanoma Induces AMPK-Dependent Autophagic Cell Death von Grazia Ambrosini, Elgilda Musi, Alan L. Ho, Elisa de Stanchina, Gary K. Schwartz

    Veröffentlicht 2013
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    Differential Regulation of Retinoblastoma Tumor Suppressor Protein by G<sub>1</sub> Cyclin-Dependent Kinase Complexes In Vivo

    Differential Regulation of Retinoblastoma Tumor Suppressor Protein by G<sub>1</sub> Cyclin-Dependent Kinase Complexes In Vivo von Sergei A. Ezhevsky, Alan L. Ho, Michelle Becker‐Hapak, Penny K. Davis, Steven F. Dowdy

    Veröffentlicht 2001
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts

    Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts von Nora Katabi, Ronald Ghossein, Alan L. Ho, Snjezana Doğan, Lei Zhang, Yun‐Shao Sung, Cristina R. Antonescu

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype

    Impact of Combined mTOR and MEK Inhibition in Uveal Melanoma Is Driven by Tumor Genotype von Alan L. Ho, Elgilda Musi, Grazia Ambrosini, Jayasree S. Nair, Shyamprasad Deraje Vasudeva, Elisa de Stanchina, Gary K. Schwartz

    Veröffentlicht 2012
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  10. 10
    Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780

    Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780 von Jayasree S. Nair, Alan L. Ho, Archie Tse, Jesse Coward, Haider Cheema, Grazia Ambrosini, Nicholas Keen, Gary K. Schwartz

    Veröffentlicht 2009
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    PDGF Receptor Alpha Is an Alternative Mediator of Rapamycin-Induced Akt Activation: Implications for Combination Targeted Therapy of Synovial Sarcoma

    PDGF Receptor Alpha Is an Alternative Mediator of Rapamycin-Induced Akt Activation: Implications for Combination Targeted Therapy of Synovial Sarcoma von Alan L. Ho, Shyamprasad Deraje Vasudeva, Marick Laé, Tsuyoshi Saito, Violetta Barbashina, Cristina R. Antonescu, Marc Ladanyi, Gary K. Schwartz

    Veröffentlicht 2012
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    The evolving landscape of salivary gland tumors

    The evolving landscape of salivary gland tumors von Conor Steuer, Glenn J. Hanna, Kartik Viswanathan, James E. Bates, Azeem Kaka, Nicole C. Schmitt, Alan L. Ho, Nabil F. Saba

    Veröffentlicht 2023
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands

    Predictors of Outcome in Adenoid Cystic Carcinoma of Salivary Glands von Bin Xu, Esther Drill, Allen S. Ho, Alan L. Ho, Lara Dunn, Carlos Nicolas Prieto-Granada, Timothy A. Chan, Ian Ganly, Ronald Ghossein, Nora Katabi

    Veröffentlicht 2017
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    The immune microenvironment and expression of PD‐L1, PD‐1, PRAME and MHC I in salivary duct carcinoma

    The immune microenvironment and expression of PD‐L1, PD‐1, PRAME and MHC I in salivary duct carcinoma von Bin Xu, Achim A. Jungbluth, Denise Frosina, Bayan Alzumaili, Nathaniel Aleynick, Elzbieta Slodkowska, Kevin Higgins, Alan L. Ho, Luc G.T. Morris, Ronald Ghossein, Nora Katabi

    Veröffentlicht 2019
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma

    Phase II Study of Lenvatinib in Patients With Progressive, Recurrent or Metastatic Adenoid Cystic Carcinoma von Vatche Tchekmedyian, Eric J. Sherman, Lara Dunn, Crystal Tran, Shrujal S. Baxi, Nora Katabi, Cristina R. Antonescu, Irina Ostrovnaya, Sofia Haque, David G. Pfister, Alan L. Ho

    Veröffentlicht 2019
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

    A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSC... von Lara Dunn, Matthew G. Fury, Han Xiao, Shrujal S. Baxi, Eric J. Sherman, Susan Korte, Christian Pfister, Sofia Haque, Nora Katabi, Alan L. Ho, David G. Pfister

    Veröffentlicht 2017
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  17. 17
    Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer

    Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer von Eric J. Sherman, Lara Dunn, Alan L. Ho, Shrujal S. Baxi, Ronald Ghossein, Matthew G. Fury, Sofia Haque, Cami S. Sima, Grace Cullen, James A. Fagin, David G. Pfister

    Veröffentlicht 2017
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    Distant metastasis of salivary gland cancer: Incidence, management, and outcomes

    Distant metastasis of salivary gland cancer: Incidence, management, and outcomes von Ximena Mimica, Marlena McGill, Ashley Hay, Daniella K. Zanoni, Jatin P. Shah, Richard J. Wong, Alan L. Ho, Marc A. Cohen, Snehal G. Patel, Ian Ganly

    Veröffentlicht 2020
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  19. 19
    Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma

    Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma von Johanna C. Bendell, Valérie André, Alan L. Ho, Ragini R. Kudchadkar, Michael R. Migden, Jeffrey R. Infante, Ramón V. Tiu, Celine Pitou, Trevor Tucker, Les Brail, Daniel D. Von Hoff

    Veröffentlicht 2018
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  20. 20
    Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers

    Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers von Brian R. Untch, Vanessa Dos Anjos, María E.R. García-Rendueles, Jeffrey A. Knauf, Gnana P. Krishnamoorthy, Mahesh Saqcena, Umesh Bhanot, Nicholas D. Socci, Alan L. Ho, Ronald Ghossein, James A. Fagin

    Veröffentlicht 2018
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: